Surprisingly, drug treatment reprogrammed Arg-1+ microglial cell phenotypes in the dentate gyrus region, suppressed neuronal inflammation, increased the quantification of hippocampal newborn neurons (BrdU+ - DCX+ cells), and improved depression-like behavior in CMS-exposed mice (156). This evidence concerns the gene ARG1 and depressive disorder.